the daily californian covers the city of berkeley and the campus in unparalleled detail, all while training the future of the journalism industry.
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
. erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
OFF DEAL